LLY

Eli Lilly stock LLY after hours on Dec. 12, 2025: Mounjaro pediatric EU nod, FDA orforglipron fast-track scrutiny, and what to watch next

Eli Lilly and Company shares ended Friday, Dec. 12, 2025 higher — and held roughly steady in after-hours trading — as investors weighed a fresh European regulatory boost for Mounjaro, new reporting on the FDA’s internal debate over speeding up

12 December 2025

Eli Lilly Stock (NYSE: LLY) in Focus: Retatrutide’s Near-30% Weight-Loss Data, FDA Fast-Track Questions for Orforglipron, and Fresh Analyst Forecasts (Dec. 12, 2025)

Eli Lilly (LLY) stock is moving as investors weigh standout retatrutide Phase 3 results, a Reuters report on FDA review timing for orforglipron, and updated Wall Street price targets. Published: December 12, 2025 Eli Lilly and Company stock (NYSE: LLY)

12 December 2025

Analyst Forecasts · FDA News · NYSE:LLY · Pharmaceuticals · Stock Market · Weight Loss

Eli Lilly (LLY) Stock: Key Catalysts to Watch Before the Market Opens on December 8, 2025

As Wall Street heads into Monday’s session, Eli Lilly and Company (NYSE: LLY) sits at the center of several big storylines: Chinese market access for its Alzheimer’s drug, a fresh FDA decision and new data for cancer therapy Jaypirca, price

7 December 2025

Financial News · Investing · Market Analysis · NYSE:LLY · Pharmaceuticals · Stock Market

Eli Lilly (LLY) Stock on December 2, 2025: Zepbound Price Cuts, GLP‑1 Boom and What Comes Next for the Trillion‑Dollar Drugmaker

Eli Lilly’s stock is trading just below record highs after a historic run driven by obesity and diabetes drugs. Fresh price cuts, powerful earnings and evolving obesity guidelines are reshaping the outlook as of December 2, 2025. Eli Lilly Stock

2 December 2025

Business News · Healthcare · Investing · NYSE:LLY · Pharmaceuticals · Stock Market

Eli Lilly (LLY) Stock Today: Trillion‑Dollar Weight‑Loss Giant Pulls Back After November Surge

By [Author Name] – November 29, 2025 Eli Lilly and Company’s stock has cooled after an explosive November rally that briefly turned the 149‑year‑old drugmaker into the world’s first trillion‑dollar pharmaceutical company. Reuters+1 On Friday, November 28, Eli Lilly (NYSE:

29 November 2025

Financial Analysis · Investment News · NYSE:LLY · Pharmaceuticals · Stock Market · Weight Loss

Eli Lilly (LLY) Stock Dips After Trillion‑Dollar Surge: November 29, 2025 Update for Investors

Eli Lilly and Company (NYSE: LLY) is catching its breath after one of the wildest runs any pharmaceutical stock has ever seen. On November 29, 2025, the share price is easing off record highs, but the company is still hovering

29 November 2025

Financial News · Investing · Market Analysis · NYSE:LLY · Pharmaceutical Industry · Stock Market

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly Stock Pre-Market Preview: Will Obesity-Drug Boom Send LLY to New Highs? (Nov 3, 2025)

Market Snapshot (pre-market Nov 3) As of Oct. 31 close, Eli Lilly (NYSE:LLY) was around $862–864 (with after-hours ~864) stockanalysis.com marketbeat.com. That’s up ~9–10% from early October nasdaq.com. Trading volumes have been heavy, and LLY remains near its 52-week high

2 November 2025

Eli Lilly · Health Industry · NYSE:LLY · Pharmaceuticals · Pre-Market · Stock Forecast

Eli Lilly (LLY) Stock Soars on Obesity-Drug Boom — Is $1,000 Next?

Stock Performance and Recent Moves Eli Lilly (NYSE: LLY) has been on a tear in October 2025. After closing around $726 on Sept. 29, the stock surged more than 9% in the following days, briefly spiking to about $832 on

23 October 2025

Financial News · Investing · NYSE:LLY · Obesity Drugs · Pharmaceuticals · Stock Market